Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study.
De Feo MS, Frantellizzi V, Bauckneht M, Farcomeni A, Filippi L, Rizzini EL, Lavelli V, Stazza ML, Di Raimondo T, Fornarini G, Rebuzzi SE, Filippo M, Mammucci P, Marongiu A, Monari F, Rubini G, Spanu A, De Vincentis G. De Feo MS, et al. Among authors: farcomeni a. Biomedicines. 2023 Apr 5;11(4):1103. doi: 10.3390/biomedicines11041103. Biomedicines. 2023. PMID: 37189721 Free PMC article.
223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature.
De Vincentis G, Follacchio GA, Frantellizzi V, Prelaj A, Farcomeni A, Giuli A, Bianco V, Tomao S. De Vincentis G, et al. Among authors: farcomeni a. Aging Clin Exp Res. 2018 Jun;30(6):677-680. doi: 10.1007/s40520-017-0826-4. Epub 2017 Aug 30. Aging Clin Exp Res. 2018. PMID: 28856577 No abstract available.
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium.
De Vincentis G, Frantellizzi V, Follacchio GA, Farcomeni A, Pani A, Samaritani R, Schinzari G, Santini D, Cortesi E. De Vincentis G, et al. Among authors: farcomeni a. Eur J Cancer Care (Engl). 2019 Sep;28(5):e13112. doi: 10.1111/ecc.13112. Epub 2019 May 31. Eur J Cancer Care (Engl). 2019. PMID: 31148330
Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study.
Frantellizzi V, Costa R, Mascia M, Spanu A, Farcomeni A, Licari M, Cindolo L, Nuvoli S, Pontico M, De Vincentis G. Frantellizzi V, et al. Among authors: farcomeni a. Clin Genitourin Cancer. 2020 Jun;18(3):185-191. doi: 10.1016/j.clgc.2019.10.009. Epub 2019 Oct 16. Clin Genitourin Cancer. 2020. PMID: 32173355
A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223.
Frantellizzi V, Monari F, Mascia M, Costa R, Rubini G, Spanu A, Farcomeni A, Lodi Rizzini E, Cindolo L, Murabito A, Lavelli V, Nuvoli S, Cosma L, Dionisi V, Nappi AG, Andreola M, De Vincentis G. Frantellizzi V, et al. Among authors: farcomeni a. Aging Clin Exp Res. 2021 Mar;33(3):651-658. doi: 10.1007/s40520-020-01573-5. Epub 2020 May 1. Aging Clin Exp Res. 2021. PMID: 32358729
236 results